Home
About
Overview
Sharing Data
ORCID
Help
History (1)
On the cost-effectiveness of the use of probiotics in inflammatory bowel disease.
See All Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
On the cost-effectiveness of the use of probiotics in inflammatory bowel disease.
Samnaliev M, Lightdale JR. On the cost-effectiveness of the use of probiotics in inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2011 Nov; 53(5):473.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Azathioprine
Colectomy
Colitis, Ulcerative
Humans
Infliximab
Mesalamine